Détail de l'auteur
Auteur J. JONES |
Documents disponibles écrits par cet auteur (4)
Ajouter le résultat dans votre panier Faire une suggestion Affiner la recherche
Article
Adaptive pathways: possible next steps for payers in preparation for their potential implementation.
P. VELLA BONANNO ; M. ERMISCH ; B. GODMAN ; A.P. MARTIN ; J. VAN DEN BERGH ; L. BEZMELNITSYNA ; A. BUCSICS ; F. ARICKX ; A. BYBAU ; T. BOCHENEK ; M. VAN DE CASTEELE ; E. DIOGENE ; I. ERIKSSON ; J. FURST ; M. GAD ; I. GREICIUTE-KUPRIJANOV ; M. VAN DER GRAAFF ; J. GULBINOVIC ; J. JONES ; R. JOPPI ; M. KALABA ; O. LAIUS ; I. LANGNER ; I. MARDARE ; V. MARKOVIC-PEKOVIC ; E. MAGNUSSON ; O. MELIEN ; D.O. MESHKOV ; G.I. PETROVA ; G. SELKE ; C. SERMET ; S. SIMOENS ; A. SCHUURMAN ; R. RAMOS ; J. RODRIGUES ; C. ZARA ; E. ZEBELIN-BRANDL ; A. HAYCOX |Medicines receiving a conditional marketing authorization through Medicines Adaptive Pathways to Patients (MAPPs) will be a challenge for payers. The “introduction” of MAPPs is already seen by the European Medicines Agency (EMA) as a fait accomp[...]Article
R.E. MALMSTROM ; B.B. GODMAN ; E. DIOGENE ; C. BAUMGARTEL ; M. BENNIE ; I. BISHOP ; A. BRZEZINSKA ; A. BUCSICS ; S. CAMPBELL ; A. FERRARIO ; A.E. FINLAYSON ; J. FURST ; K. GARUOLIENE ; M. GOMES ; I. GUTIERREZ-IBARLUZEA ; A. HAYCOX ; K. HVIDING ; H. HERHOLZ ; M. HOFFMANN ; S. JAN ; J. JONES ; R. JOPPI ; M. KALABA ; C. KVALHEIM ; O. LAIUS ; I. LANGNER ; J. LONSDALE ; S.A. LOOV ; K. MALINOWSKA ; L. MCCULLAGH ; K. PATERSON ; V. MARKOVIC-PEKOVIC ; A. MARTIN ; J. PIESSNEGGER ; G. SELKE ; C. SERMET |There are potential conflicts between authorities and companies to fund new premium priced drugs especially where there are safety and/or budget concerns. Dabigatran, a new oral anticoagulant for the prevention of stroke in patients with non-val[...]Article
M. ERMISCH ; A. BUCSICS ; P. VELLA BONANNO ; F. ARICKX ; A. BYBAU ; T. BOCHENEK ; M. VAN DE CASTEELE ; E. DIOGENE ; J. FURST ; K. GARUOLIENE ; M. VAN DER GRAAFF ; J. GULBINOVIC ; A. HAYCOX ; J. JONES ; R. JOPPI ; O. LAIUS ; I. LANGNER ; A. P. MARTIN ; V. MARKOVIC-PEKOVIC ; L. MCCULLAGH ; E. MAGNUSSON ; E. NILSEN ; G. SELKE ; C. SERMET ; S. SIMOENS ; R. SAUERMANN ; A. SCHUURMAN ; R. RAMOS ; V. VLAHOVIC-PALCEVSKI ; C. ZARA ; B. GODMAN |Payers are a major stakeholder in any considerations and initiatives concerning adaptive licensing of new medicinal products, also referred to as Medicines Adaptive Pathways to patients (MAPPs). Firstly, the scope and necessity of MAPPs need fur[...]Article
B. GODMAN ; A.E. FINLAYSON ; P.K. CHEEMA ; E. ZEBEDIN-BRANDL ; I. GUTIERREZ-IBARLUZEA ; J. JONES ; R.E. MALMSTROM ; E. ASOLA ; C. SERMET ; et al. |Considerable variety in how patients respond to treatments, driven by differences in their geno- and/ or phenotypes, calls for a more tailored approach. This is already happening, and will accelerate with developments in personalized medicine. H[...]